VikiSoh
2021-06-01
Why
$Pfizer(PFE)$
price is hardly break through 42?
UPDATE 1-India plans to more than triple COVID-19 vaccine shots per day
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
1
6
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":119434320,"tweetId":"119434320","gmtCreate":1622558008560,"gmtModify":1634100478607,"author":{"id":3578172115401354,"idStr":"3578172115401354","authorId":3578172115401354,"authorIdStr":"3578172115401354","name":"VikiSoh","avatar":"https://static.tigerbbs.com/2130cfe283666b13556b33ac1d8d56e0","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":231,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Why <a href=\"https://laohu8.com/S/PFE\">$Pfizer(PFE)$</a>price is hardly break through 42?</p></body></html>","htmlText":"<html><head></head><body><p>Why <a href=\"https://laohu8.com/S/PFE\">$Pfizer(PFE)$</a>price is hardly break through 42?</p></body></html>","text":"Why $Pfizer(PFE)$price is hardly break through 42?","highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/119434320","repostId":2140873498,"repostType":2,"repost":{"id":"2140873498","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1622555355,"share":"https://www.laohu8.com/m/news/2140873498?lang=&edition=full","pubTime":"2021-06-01 21:49","market":"fut","language":"en","title":"UPDATE 1-India plans to more than triple COVID-19 vaccine shots per day","url":"https://stock-news.laohu8.com/highlight/detail?id=2140873498","media":"Reuters","summary":"(Recasts, updates throughout) By Manas Mishra and Tanvi Mehta BENGALURU, June 1 (Reuters) - Indi","content":"<html><body><p>(Recasts, updates throughout)</p><p> By Manas Mishra and Tanvi Mehta</p><p> BENGALURU, June 1 (Reuters) - India could have as many as 10 million doses of COVID-19 vaccines available per day in July and August, compared with just under three million now, the government said, trying to allay concerns about shortages and mishandling of the programme.</p><p> The world's second most populous country has suffered a disastrous outbreak of infections since April that is only now abating and health experts say the only way it can avert another surge is mass vaccination of its 1.3 billion people.</p><p> \"We don’t doubt that we will be able to increase the pace of vaccinations, once supply is ramped up,\" government advisor V K Paul told reporters on Tuesday. </p><p> Vaccine manufacturers such as Serum Institute of India and Bharat Biotech are scrambling to boost supplies, with the country is also in talks with major foreign vaccine producers such as Pfizer Inc , officials have said. </p><p> The health ministry said nearly 45 million people had been fully vaccinated - 4.7% of the country's 950 million adult population. India administered nearly 2.8 million doses on Monday, according to data from its official vaccine portal.</p><p> Prime Minister Narendra Modi's government has drawn criticism for a slow vaccine rollout even though India is <a href=\"https://laohu8.com/S/AONE\">one</a> of the world's biggest manufacturers of doses, including AstraZeneca's shot.</p><p> Several states have complained of a shortage of the AstraZenca vaccines and another called Covaxin, developed by Indian firm Bharat Biotech.</p><p> Last month, the government ordered that the interval between two doses of AstraZeneca be increased to 12-16 weeks from 4-6 weeks, which experts said was because of tight supplies. </p><p> Paul said there was no plan to mix doses of different vaccines that some officials had suggested earlier. He also said everyone was recommended to take the full two doses of AstraZeneca's vaccine and not limit themselves to <a href=\"https://laohu8.com/S/AONE.U\">one</a> shot.</p><p> \"India's Covishield schedule is of two doses... there is no change, and Covaxin is also for two doses,\" Paul said. </p><p> On Tuesday the country reported its lowest daily rise in new coronavirus infections in over a month, at 127,510, while deaths rose by 2,795 - its lowest daily increase since April 27. </p><p> \"Containment has worked. However, it is not a sustainable solution and we have to find a measure to ease the lockdowns,\" said Balram Bhargava, head of the Indian Council of Medical Research. </p><p> The giant South Asian nation's overall toll of infections now stands at 28.2 million, while the number of deaths has reached 331,895, according to health ministry data. </p><p> (Reporting by Manas Mishra and Nallur Sethuraman in Bengaluru, Tanvi Mehta in New Delhi Editing by Sanjeev Miglani and Mark Heinrich)</p><p>((Sethuraman.NR@thomsonreuters.com; (+91 8061822737); Reuters Messaging: nallur.sethuraman.thomsonreuters.com@reuters.net))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>UPDATE 1-India plans to more than triple COVID-19 vaccine shots per day</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUPDATE 1-India plans to more than triple COVID-19 vaccine shots per day\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-01 21:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>(Recasts, updates throughout)</p><p> By Manas Mishra and Tanvi Mehta</p><p> BENGALURU, June 1 (Reuters) - India could have as many as 10 million doses of COVID-19 vaccines available per day in July and August, compared with just under three million now, the government said, trying to allay concerns about shortages and mishandling of the programme.</p><p> The world's second most populous country has suffered a disastrous outbreak of infections since April that is only now abating and health experts say the only way it can avert another surge is mass vaccination of its 1.3 billion people.</p><p> \"We don’t doubt that we will be able to increase the pace of vaccinations, once supply is ramped up,\" government advisor V K Paul told reporters on Tuesday. </p><p> Vaccine manufacturers such as Serum Institute of India and Bharat Biotech are scrambling to boost supplies, with the country is also in talks with major foreign vaccine producers such as Pfizer Inc , officials have said. </p><p> The health ministry said nearly 45 million people had been fully vaccinated - 4.7% of the country's 950 million adult population. India administered nearly 2.8 million doses on Monday, according to data from its official vaccine portal.</p><p> Prime Minister Narendra Modi's government has drawn criticism for a slow vaccine rollout even though India is <a href=\"https://laohu8.com/S/AONE\">one</a> of the world's biggest manufacturers of doses, including AstraZeneca's shot.</p><p> Several states have complained of a shortage of the AstraZenca vaccines and another called Covaxin, developed by Indian firm Bharat Biotech.</p><p> Last month, the government ordered that the interval between two doses of AstraZeneca be increased to 12-16 weeks from 4-6 weeks, which experts said was because of tight supplies. </p><p> Paul said there was no plan to mix doses of different vaccines that some officials had suggested earlier. He also said everyone was recommended to take the full two doses of AstraZeneca's vaccine and not limit themselves to <a href=\"https://laohu8.com/S/AONE.U\">one</a> shot.</p><p> \"India's Covishield schedule is of two doses... there is no change, and Covaxin is also for two doses,\" Paul said. </p><p> On Tuesday the country reported its lowest daily rise in new coronavirus infections in over a month, at 127,510, while deaths rose by 2,795 - its lowest daily increase since April 27. </p><p> \"Containment has worked. However, it is not a sustainable solution and we have to find a measure to ease the lockdowns,\" said Balram Bhargava, head of the Indian Council of Medical Research. </p><p> The giant South Asian nation's overall toll of infections now stands at 28.2 million, while the number of deaths has reached 331,895, according to health ministry data. </p><p> (Reporting by Manas Mishra and Nallur Sethuraman in Bengaluru, Tanvi Mehta in New Delhi Editing by Sanjeev Miglani and Mark Heinrich)</p><p>((Sethuraman.NR@thomsonreuters.com; (+91 8061822737); Reuters Messaging: nallur.sethuraman.thomsonreuters.com@reuters.net))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2140873498","content_text":"(Recasts, updates throughout) By Manas Mishra and Tanvi Mehta BENGALURU, June 1 (Reuters) - India could have as many as 10 million doses of COVID-19 vaccines available per day in July and August, compared with just under three million now, the government said, trying to allay concerns about shortages and mishandling of the programme. The world's second most populous country has suffered a disastrous outbreak of infections since April that is only now abating and health experts say the only way it can avert another surge is mass vaccination of its 1.3 billion people. \"We don’t doubt that we will be able to increase the pace of vaccinations, once supply is ramped up,\" government advisor V K Paul told reporters on Tuesday. Vaccine manufacturers such as Serum Institute of India and Bharat Biotech are scrambling to boost supplies, with the country is also in talks with major foreign vaccine producers such as Pfizer Inc , officials have said. The health ministry said nearly 45 million people had been fully vaccinated - 4.7% of the country's 950 million adult population. India administered nearly 2.8 million doses on Monday, according to data from its official vaccine portal. Prime Minister Narendra Modi's government has drawn criticism for a slow vaccine rollout even though India is one of the world's biggest manufacturers of doses, including AstraZeneca's shot. Several states have complained of a shortage of the AstraZenca vaccines and another called Covaxin, developed by Indian firm Bharat Biotech. Last month, the government ordered that the interval between two doses of AstraZeneca be increased to 12-16 weeks from 4-6 weeks, which experts said was because of tight supplies. Paul said there was no plan to mix doses of different vaccines that some officials had suggested earlier. He also said everyone was recommended to take the full two doses of AstraZeneca's vaccine and not limit themselves to one shot. \"India's Covishield schedule is of two doses... there is no change, and Covaxin is also for two doses,\" Paul said. On Tuesday the country reported its lowest daily rise in new coronavirus infections in over a month, at 127,510, while deaths rose by 2,795 - its lowest daily increase since April 27. \"Containment has worked. However, it is not a sustainable solution and we have to find a measure to ease the lockdowns,\" said Balram Bhargava, head of the Indian Council of Medical Research. The giant South Asian nation's overall toll of infections now stands at 28.2 million, while the number of deaths has reached 331,895, according to health ministry data. (Reporting by Manas Mishra and Nallur Sethuraman in Bengaluru, Tanvi Mehta in New Delhi Editing by Sanjeev Miglani and Mark Heinrich)((Sethuraman.NR@thomsonreuters.com; (+91 8061822737); Reuters Messaging: nallur.sethuraman.thomsonreuters.com@reuters.net))","news_type":1},"isVote":1,"tweetType":1,"viewCount":464,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["PFE"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":44,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/119434320"}
精彩评论